Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,127 | -8,850 | -3,511 | 1,322 | -2,523 |
| Depreciation Amortization | 337 | 252 | 197 | 480 | 373 |
| Accounts receivable | -57 | 9 | -355 | 820 | 831 |
| Other Working Capital | -193 | 33 | -197 | -1,187 | -980 |
| Other Operating Activity | 4,376 | 7,689 | 3,244 | -5,018 | -397 |
| Operating Cash Flow | $-1,664 | $-867 | $-622 | $-3,583 | $-2,696 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 3 | 3 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $3 | $3 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,610 | N/A | N/A | 2,800 | 1,300 |
| Debt Repayment | -1,500 | -1,500 | -1,500 | -1,300 | -1,300 |
| Common Stock Issued | 2,024 | 2,015 | 2,017 | 3,019 | 3,019 |
| Other Financing Activity | 0 | 0 | 0 | -399 | -204 |
| Financing Cash Flow | $2,134 | $515 | $517 | $4,120 | $2,815 |
| Exchange Rate Effect | -2 | -2 | -1 | -8 | -1 |
| Beginning Cash Position | 579 | 579 | 579 | 47 | 47 |
| End Cash Position | 1,047 | 225 | 473 | 579 | 168 |
| Net Cash Flow | $468 | $-354 | $-106 | $532 | $121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,664 | -867 | -622 | -3,583 | -2,696 |
| Free Cash Flow | -1,664 | -867 | -622 | -3,583 | -2,696 |